Chronic Hepatitis B treatment vaccine.   HeberNasVac; Also known as A.B.X.203 

A.B.X.203 is a therapeutic vaccine designed to stimulate the immune system in individuals already infected with hepatitis B. Unlike traditional vaccines that primarily focus on preventing infection, A.B.X.203 is geared towards helping the immune system control and eliminates the virus in those who are already chronically infected.
The unique aspect of this vaccine lies in its ability to stimulate the patient's immune system to recognize and combat the virus, ultimately killing the virus, reducing the severity of the infection and preventing disease progression.
In 80% of the people treated, the presence of the virus in the blood is considerably decreased and in 50 %, the viral load is not detectable, even five years after stopping the vaccine.
A.B.X.203, a therapeutic vaccine designed to address the challenges posed by chronic hepatitis B infection. Developed by Center for Genetic Engineering and Biotechnology C.I.G.B in Cuba. HeberNasVac also known as A.B.X.203, represents a significant breakthrough in the fight against this persistent and potentially life-threatening viral infection.
OURWEBSITE;
zoomhospital.com/
Chat with us ;
wa.me/message/ES2SVK2FZHZEN1
Related videos;
• Treatment of hepatitis...
• How to avoid hepatitis...
• The danger of Hepatiti...
• How you can make your ...
• Causes of liver damage...
• Drugs to cure Hepatiti...
• Why hepatitis B is dif...
• New hepatitis B infect...
• how to cure hepatitis ...
• Hepatitis C Cure and T...
Our website zoomhospital.com/